Credit Suisse Group AG Reaffirms Underperform Rating for AstraZeneca plc


's stock had its "underperform" rating reaffirmed by research analysts at Credit Suisse Group AG in a report released on Friday. They currently have a GBX 4,000 target price on the biopharmaceutical company's stock.



from Biotech News